- Home
- LPSN vs EPRX Comparison
LPSN vs EPRX Comparison
Compare LPSN & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- EPRX
- Stock Information
- Founded
- LPSN 1995
- EPRX 2011
- Country
- LPSN United States
- EPRX Canada
- Employees
- LPSN N/A
- EPRX N/A
- Industry
- LPSN EDP Services
- EPRX
- Sector
- LPSN Technology
- EPRX
- Exchange
- LPSN Nasdaq
- EPRX NYSE
- Market Cap
- LPSN 93.0M
- EPRX 85.5M
- IPO Year
- LPSN 2000
- EPRX N/A
- Fundamental
- Price
- LPSN $0.81
- EPRX $3.37
- Analyst Decision
- LPSN Hold
- EPRX
- Analyst Count
- LPSN 6
- EPRX 0
- Target Price
- LPSN $1.18
- EPRX N/A
- AVG Volume (30 Days)
- LPSN 2.1M
- EPRX 33.3K
- Earning Date
- LPSN 11-07-2024
- EPRX 11-07-2024
- Dividend Yield
- LPSN N/A
- EPRX N/A
- EPS Growth
- LPSN N/A
- EPRX N/A
- EPS
- LPSN N/A
- EPRX N/A
- Revenue
- LPSN $334,736,000.00
- EPRX N/A
- Revenue This Year
- LPSN N/A
- EPRX N/A
- Revenue Next Year
- LPSN N/A
- EPRX N/A
- P/E Ratio
- LPSN N/A
- EPRX N/A
- Revenue Growth
- LPSN N/A
- EPRX N/A
- 52 Week Low
- LPSN $0.45
- EPRX $2.20
- 52 Week High
- LPSN $3.98
- EPRX $4.08
- Technical
- Relative Strength Index (RSI)
- LPSN 34.02
- EPRX N/A
- Support Level
- LPSN $0.76
- EPRX N/A
- Resistance Level
- LPSN $0.86
- EPRX N/A
- Average True Range (ATR)
- LPSN 0.08
- EPRX 0.00
- MACD
- LPSN -0.02
- EPRX 0.00
- Stochastic Oscillator
- LPSN 13.74
- EPRX 0.00
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation.. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.